On March 23, 2018, the Centers for Medicare & Medicaid Services
(CMS) published in the Federal Register the final notice for the Medicaid
National Drug Rebate Agreement (NDRA) (83 FR 12770) that announced changes to
the NDRA which were applicable as of the March 23, 2018 publication date. The
Federal Notice is available at the following link: https://www.federalregister.gov/documents/2018/03/23/2018-05947/medicaid-program-announcement-of-medicaid-drug-rebate-program-national-rebate-agreement.
On March 26, 2018, CMS released guidance to manufacturers through
Manufacturer Release #108 which provides additional information to
manufacturers as to the actions required for current manufacturers to remain
active in the Medicaid Drug Rebate Program. The release is now available for
download at the following link: https://www.medicaid.gov/medicaid/prescription-drugs/program-releases/index.html.
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, March 27, 2018
Announced changes to the NDRA which were applicable as of the March 23, 2018 publication date.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment